Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Displaying 2295 questions Show Answers

Order by |

Question reference: S5W-07727

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 20 March 2017

To ask the Scottish Government whether it will allow (a) transobturator mesh tape and (b) prolapse mesh procedures to be used after the Independent Review of Transvaginal Mesh Implants reports.

Question reference: S5W-07739

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 20 March 2017

To ask the Scottish Government for what reason the Chief Medical Officer said in December 2016 that there was no other alternative treatments for stress urinary incontinence and pelvic organ prolapse other than mesh when, prior to mesh being developed from the late 1990s, it is understood that non-mesh treatments were the most common form of treatment.

This does not accurately reflect the Chief Medical Officer’s position. In 2014 the Acting Chief Medical Officer wrote to all Health boards requesting that they consider the suspension of the use of mesh to treat stress urinary incontinence and pelvic organ prolapse. In doing so, the Acting chief Medical Officer asked that, before coming to a decision, Health Boards carefully consider evidence relating to both mesh treatments and its alternatives. The present Chief Medical Officer further wrote to Health boards in 2015 to confirm that the request to suspend procedures remained in place, and also to direct Health Boards to the Patient Information and Consent Leaflet, which notes all alternative treatments in relation to stress urinary incontinence.

Question reference: S5W-07753

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government what administrative, emotional and legal support it provides to lay members of the Independent Review of Transvaginal Mesh Implants group who have resigned.

The Independent Review’s secretariat has provided support to all members of the Review. This has included, amongst other things, the arranging meetings at convenient times and in appropriate accommodation, the arranging of teleconferencing facilities, the provision of hard copy papers, the refunding of travelling expenses, and other assistance upon request. Scottish Government officials are unable to provide legal advice.

Question reference: S5W-07751

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government what assessment it has made of the average cost of (a) mesh and (b) non-mesh treatments for stress urinary incontinence and pelvic organ prolapse.

Question reference: S5W-07748

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government how many pending legal cases there are that involve the use of medical mesh devices to treat hernias.

Question reference: S5W-07752

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government whether it will recommend making it mandatory to (a) use a medical mesh device registry and (b) report adverse events involving medical mesh devices and, if not, what other methods it will use to record the number and extent of adverse incidents involving these devices.

Question reference: S5W-07754

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government on what dates it has met the Medicines and Healthcare products Regulatory Agency since the interim report from the Independent Review of Transvaginal Mesh Implants was published in October 2015.

Scottish Government staff have participated in formal Cross-UK forum meetings with the MHRA, regarding pharmacy and medical device issues, in January 2016, April 2016, July 2016, October 2016 and January 2017. A meeting also took place between Scottish Government officials, Health Facilities Scotland and MHRA in February 2017.

Other ad-hoc meetings involving a range of Scottish Government staff have taken place as required.

Question reference: S5W-07743

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government how many legal cases have been lodged in relation to non-mesh treatments for stress urinary incontinence and pelvic organ prolapse in Scotland.

Question reference: S5W-07746

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government how many adverse incidents there have been involving the use of medical mesh devices to treat hernias.

Question reference: S5W-07755

Asked by: Neil Findlay, MSP for Lothian, Scottish Labour
Date lodged: Monday, 06 March 2017
Current Status: Answered by Shona Robison on 17 March 2017

To ask the Scottish Government whether the Medicines and Health Care products Regulatory Agency expressed an opinion on the Interim report of the Independent Review of Transvaginal Mesh implants, which was published in October 2015.